« Back
Home /
MYCL1 Blocking Peptide (C-Term)

MYCL1 Blocking Peptide (C-Term)

Item no.	ABC-BP21488b
Manufacturer	Abcepta
Amount	500 ug
Category	Oncology By Cell Type Blastoma Carcinoma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Peptides & Proteins Peptides By Organ Bladder Cancer
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	DePinho R.A.,et al.Genes Dev. 1:1311-1326(1987). Kaye F.,et al.Mol. Cell. Biol. 8:186-195(1988). Ota T.,et al.Nat. Genet. 36:40-45(2004). Gregory S.G.,et al.Nature 441:315-321(2006). Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Protein L-Myc,Class E basic helix-loop-helix protein 38,bHLHe38,Protein L-Myc-1,V-myc myelocytomatosis viral oncogene homolog,MYCL,BHLHE38,LMYC,MYCL1
Similar products	MYCL1, LMYC, MYCL, bHLHe38, BHLHE38, Protein L-Myc-1, Protein L-Myc, Class E basic helix-loop-helix protein 38, V-myc myelocytomatosis viral oncogene homolog
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence is selected from aa 271-283 of HUMAN MYCL
Gene Name	MYCL
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP21488b-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 13 days

Compare

Add to wishlist

Get an offer